Dihexa, also known by its chemical designation N-hexanoic-Tyr-Ile-(6) aminohexanoic amide , is a small peptide originally developed by researchers at Washington State University
Agent-induced gastric lesion models , a cytotoxic agent producing stomach and duodenal lesions, where the damage was framed as a nitric oxide system disturbance Cyclophosphamide , producing stomach lesions in mice, with BPC-157 showing attenuation alongside omeprazole and bromocriptine while several other agents did not Haloperidol , relevant since non-steroidal anti-inflammatory drugs are among the most common causes of gastric mucosal injury NSAID-type damage The proposed mechanism combines increased mucosal perfusion with direct cytoprotection, consistent with the broader mechanistic picture
Our bodies do not produce vitamin B12, and these B vitamins are water-soluble so our body does not store them either
In controlled research settings, this compound is used to investigate: peptidereceptor interaction dynamics molecular signalling pathways biochemical behaviour within experimental systems Research involving this compound is conducted strictly in non-clinical environments
When to Contact Us (Seek Medical Advice if You Experience): Fever of 100.4F (38C) or higher Blistering at the injection site Muscle aches, nausea, dizziness, or headache Skin rash, severe itching, vomiting, or hives For any questions, please contact your healthcare provider